Biotechs seeking alternative sources for funding

A number of biotech companies are seeking funding from royalty financing, project financing, reverse mergers and structured financing details from which they might previously have not tapped, according to Reuters.

The reason is that they have had difficulty getting funding through initial public offerings. In response, some private investors have invested money in public biotech companies, while companies with products but no money have bought companies with the opposite problem.